Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
HE Nagels, JR Rishworth… - Cochrane Database …, 2015 - cochranelibrary.com
Background Infertility is a condition affecting 10% to 15% of couples of reproductive age. It is
generally defined as" the failure to achieve a clinical pregnancy after 12 months or more of …
generally defined as" the failure to achieve a clinical pregnancy after 12 months or more of …
Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
G Lin, X Li, SL Jin Yie, L Xu - Annals of Medicine, 2024 - Taylor & Francis
Background To quantitatively evaluate the effect of coenzyme Q10 (CoQ10) pretreatment on
outcomes of IVF or ICSI in women with diminished ovarian reserve (DOR) based on the …
outcomes of IVF or ICSI in women with diminished ovarian reserve (DOR) based on the …
Comparative efficacy of different growth hormone supplementation protocols in improving clinical outcomes in women with poor ovarian response undergoing …
Z Xu, W Tong, Z Yang, H Zhang, X Chen - Scientific Reports, 2024 - nature.com
Growth hormone (GH) has a long-standing history of use as an adjunctive therapy in the
treatment of poor ovarian response (POR), but the optimal dosage and timing remains …
treatment of poor ovarian response (POR), but the optimal dosage and timing remains …
The cumulative live birth rate and cost-effectiveness of the clomiphene and gonadotropin cotreatment protocol versus the mid-luteal GnRH agonist protocol in women …
Y Li, D Luo, T Li, H Ding, Y Liu - Scientific Reports, 2024 - nature.com
The decrease in assisted reproductive technology success among older women, attributed
to decreased oocyte quantity and quality, poses a significant challenge. Currently, no …
to decreased oocyte quantity and quality, poses a significant challenge. Currently, no …
Efficacy and safety of Shen Que (RN8) moxibustion on reproductive outcomes in unexpected poor ovarian responders: a randomized controlled trial
JY Song, ZG Sun, YX Ma - Journal of Ovarian Research, 2024 - Springer
Background Managing infertility patients with poor ovarian response (POR) to ovarian
stimulation remains unmet clinically. Besides economic burdens, patients with POR have a …
stimulation remains unmet clinically. Besides economic burdens, patients with POR have a …
[HTML][HTML] Регуляция активности инозитолфосфатных сигнальных путей у пациенток с «бедным» ответом яичников. Возможности адъювантной терапии
ЕА Заковряшин, ИЕ Корнеева… - … и гинекология: Новости …, 2024 - cyberleninka.ru
Представлена информация об инозитолфосфатных сигнальных путях, выступающих
ключевыми регуляторами роста и созревания ооцита. Обсуждается применение …
ключевыми регуляторами роста и созревания ооцита. Обсуждается применение …
Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health
IA Silić - Science Insights, 2023 - bonoi.org
Abstract Coenzyme Q10 (CoQ10) is an endogenous molecule that is ubiquitously found
throughout the cellular composition of the human organism. The aforementioned substance …
throughout the cellular composition of the human organism. The aforementioned substance …
Comparing Clomiphene-Primed Ovarian Stimulation and Mid-Luteal GnRH Agonist Protocols: A Cumulative Live Birth Rate and Cost-Effectiveness Analysis in a …
Y Li, D Luo, T Li, H Ding, Y Liu - 2023 - preprints.org
The decline in assisted reproductive technology (ART) success among older women,
attributed to decreased oocyte quantity and quality, poses a significant challenge. Currently …
attributed to decreased oocyte quantity and quality, poses a significant challenge. Currently …